Zhou Zhi Dong, Sathiyamoorthy Sushmitha, Angeles Dario C, Tan Eng King
National Neuroscience Institute of Singapore, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore.
Signature Research Program in Neuroscience and Behavioural Disorders, Duke-NUS Graduate Medical School Singapore, 8 College Road, Singapore, 169857, Singapore.
Mol Brain. 2016 Apr 18;9:41. doi: 10.1186/s13041-016-0218-2.
Mutations of F-box protein 7 (FBXO7) and Parkin, two proteins in ubiquitin-proteasome system (UPS), are both implicated in pathogenesis of dopamine (DA) neuron degeneration in Parkinson's disease (PD). Parkin is a HECT/RING hybrid ligase that physically receives ubiquitin on its catalytic centre and passes ubiquitin onto its substrates, whereas FBXO7 is an adaptor protein in Skp-Cullin-F-box (SCF) SCF(FBXO7) ubiquitin E3 ligase complex to recognize substrates and mediate substrates ubiquitination by SCF(FBXO7) E3 ligase. Here, we discuss the overlapping pathophysiologic mechanisms and clinical features linking Parkin and FBXO7 with autosomal recessive PD. Both proteins play an important role in neuroprotective mitophagy to clear away impaired mitochondria. Parkin can be recruited to impaired mitochondria whereas cellular stress can promote FBXO7 mitochondrial translocation. PD-linked FBXO7 can recruit Parkin into damaged mitochondria and facilitate its aggregation. WT FBXO7, but not PD-linked FBXO7 mutants can rescue DA neuron degeneration in Parkin null Drosophila. A better understanding of the common pathophysiologic mechanisms of these two proteins could unravel specific pathways for targeted therapy in PD.
泛素-蛋白酶体系统(UPS)中的两种蛋白质,即F-box蛋白7(FBXO7)和帕金蛋白的突变,均与帕金森病(PD)中多巴胺(DA)神经元变性的发病机制有关。帕金蛋白是一种HECT/RING杂合连接酶,在其催化中心物理性地接收泛素并将泛素传递给其底物,而FBXO7是Skp-Cullin-F-box(SCF)SCF(FBXO7)泛素E3连接酶复合物中的衔接蛋白,用于识别底物并介导SCF(FBXO7) E3连接酶对底物的泛素化。在此,我们讨论将帕金蛋白和FBXO7与常染色体隐性PD联系起来的重叠病理生理机制和临床特征。这两种蛋白质在清除受损线粒体的神经保护性线粒体自噬中都发挥着重要作用。帕金蛋白可以被招募到受损线粒体,而细胞应激可以促进FBXO7向线粒体的转位。与PD相关的FBXO7可以将帕金蛋白招募到受损线粒体并促进其聚集。野生型FBXO7而非与PD相关的FBXO7突变体可以挽救帕金蛋白缺失的果蝇中的DA神经元变性。更好地理解这两种蛋白质的共同病理生理机制可能会揭示PD靶向治疗的特定途径。